# FDA 483 - Samson Pharmaceuticals, Inc - April 29, 2026

Source: https://www.keypedia.com/records/483/samson-pharmaceuticals-inc/aa36e793-e90c-4cb7-a6ac-9edcf3fc3868

> FDA 483 for Samson Pharmaceuticals, Inc on April 29, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Samson Pharmaceuticals, Inc
- Inspection Date: 2026-04-29
- Product Type: drugs
- Office Name: Los Angeles District Office
- Summary: An FDA inspection of Samson Pharmaceuticals, Inc. in Commerce, CA, revealed significant deficiencies across its quality control, aseptic processing, and laboratory systems. The firm lacked written procedures for quality control, failed to prevent microbiological contamination, and did not adequately investigate out-of-specification results. These issues indicate a systemic breakdown in ensuring the quality and sterility of its drug products.

## Related Documents

- [483 - 2016-03-25](https://www.keypedia.com/records/483/samson-pharmaceuticals-inc/d5786061-88a5-4ecf-8308-1ddb88964b69)
- [483 - 2020-01-29](https://www.keypedia.com/records/483/samson-pharmaceuticals-inc/6a261834-0d6e-41d0-9499-806127bab329)

## Related Officers

- [Chemist/Investigator - Pharmaceutical Quality](https://www.keypedia.com/people/walden-h-lee/18131eea-d1cb-47c4-af79-bea22d436031)
- [Consumer Safety Officer, Drug Specialist](https://www.keypedia.com/people/taichun-qin/62349336-96d6-4452-9c20-9084204b86bf)
- [Luis P. Torres](https://www.keypedia.com/people/luis-p-torres/995f71e1-b7b8-4c30-9d53-2127b01f8d47)
- [Luis F. Torres](https://www.keypedia.com/people/luis-f-torres/0b42aa90-0fa3-407d-bc65-75e270c4dec1)

Company: https://www.keypedia.com/companies/samson-pharmaceuticals-inc/4250f533-840c-44d3-a3e7-cc538c63ca03

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b